PARLIAMENTARY WRITTEN QUESTION
Coagadex (19 April 2018)
Question Asked
Asked by:
Fabian Hamilton (Labour)
Answer
At present, NHS England does not routinely commission Coagadex for any indication.
A commissioning policy proposal for the prescribing of Coagedex for patients with the hereditary factor X deficiency bleeding disorder has been developed. The Clinical Priorities Advisory Group (CPAG) makes recommendations on NHS England's approach to commissioning services, treatments and technologies, and considers which of these should be prioritised for investment. The CPAG will make its recommendations regarding the commissioning of Coagadex to NHS England in May 2018.
Answered by:
Steve Brine (Conservative)
26 April 2018
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.